ARTICLE | Company News
ChromaVision, NewBiotics imaging deal
November 6, 2002 8:00 AM UTC
CVSN will use its ACIS digital imaging system to analyze tissue samples from colon cancer patients enrolled in NewBiotics' Phase I and II trials of Thymectacin. NewBiotics (San Diego, Calif.) will pay...